SlideShare a Scribd company logo
1 of 1
Background
Materials and Methods
In vitro blood testing is used in numerous settings including in
laboratories and clinical offices. These diagnostic tests are used to
detect a variety of medical complications. The reliability of such
tools may be compromised by factors such as blood age, blood-
device interactions, and the blood drawing procedure. Hemolysis,
which refers to the rupture of red blood cells, releases hemoglobin
into the plasma. Therefore, we have characterized healthy and
damaged blood at different time points after it has been drawn to
evaluate the viability of blood and to determine which blood
parameters are likely to be affected.
• To study and compare blood characteristics at different blood
ages (time after blood draw)
• To compare the blood characteristics and fragility parameters of
different species (porcine, human).
The results of this research are intended to improve in vitro
blood testing methodologies.
Blood Parameters:
To study the change in blood characteristics due to blood
aging, the blood was tested on different days. When not in use, the
blood was kept refrigerated. The following conditions were used for
testing:
• Hematocrit was adjusted to 36%
• Anticoagulation was achieved with either acid citrate dextrose
solution A (ACDA) (for porcine and human blood) or 3.2%
sodium citrate (for human blood only)
• Blood Age: fresh blood (Day 1), Day 3 blood, and Day 8 blood
• Blood Species: porcine and human
Day 1 human Day 8 human
plasma plasma
Rocker Bead Fragility Test:
Four tubes were rocked, with 15 stainless steel beads in each, in
order to test blood fragility on Day 1. The following conditions were
used for this test:
• 3 mL of blood
• 24º rocking angle
• 30 minute run time
• 30 cycles per minute
Blood Characterization Tests:
The density of each sample was found by weighing 1.000 ml of
blood on a balance and making three measurements.
A Complete Blood Count (CBC) System was used to determine
the RBC count, WBC count, platelet count, and mean cell
volume (MCV) of each blood sample.
pH and partial pressure of oxygen (P O2) and carbon dioxide
(P CO2) were measured using a blood gas analyzer.
Plasma protein concentration was measured optically using a
total solids refractometer.
Blood and plasma viscosity and elasticity were measured by
loading 0.5 ml of blood into an oscillatory rheometer, which uses a
piston to generate oscillatory blood flow through a small diameter
tube at known shear stresses. Viscosity was measured over a
shear rate range of 5 to 1000 1/s.
The Impact of Blood Age and Mechanical Damage
on Measured Physical Parameters of Red Blood Cells
Naomi Dereje, Luke Herbertson, Richard Malinauskas
OSEL/Division of Applied Mechanics
Results
Blood
Age
Viscosity
(cP) @
1000 1/s
Plasma
Protein
(g/dL)
Glucose
(mg/dL)
P O2
(mmHg)
P CO2
(mmHg)
pH
RBC Count
(*1012
/L)
MCV (fL)
Platelet
Count
(*109
/L)
Plasma
Free Hb
(mg/dL)
Day 1 2.52±0.21 5.7±0.7 89±29 34±6 38±1 7.4±0 3.94±0.62 90.3±10.4 165±30 1.9±0.8
Human
3.2% Na
Cit
Day 3 2.88±0.61 6.3±0.7 60±13 50 42 7.3 4.08±0.12 84.4±2.1 114±57 28.2±8.6
Day 8 2.64±0.45 6.1±0.3 23±15 176 18 7.4 4.08±0.28 83.3±5.2 134±26 136.8±45.0
Day 1 2.47±0.04 6.1±0.6 418±40 71±6 67±15 6.8±0.1 6.78±0.81 55.1±2.7 247±80 14.0±5.7
Porcine
ACDA
Day 3 2.68±0.22 6.5±0.9 411±45 72±9 46±17 6.9±0.1 6.09±0.19 54.1±1.9 260±77 31.1±9.9
Day 8 2.64±0.18 6.6±0.6 411±34 82±7 36±3 6.9±0 6.03±0.28 55.0±2.6 278±78 53.7±10.3
The following table displays the different characteristics of
each blood pool. For sodium citrate human blood we observed
most of the parameters measured were not affected by blood
age, however platelet count and P CO2 decreased while P O2
increased. For ACDA porcine blood, the difference is seen in the
platelet count, which increased instead. Other trends are similar,
but the anticoagulant appears to improve the long term viability of
the blood.
Blood Age Effects:
The figure to the right
compares the plasma free
hemoglobin levels of human
blood and porcine blood on each
test day, showing the damage
effects of blood aging. It should
be noted that the human blood
was anticoagulated with sodium
0
20
40
60
80
100
120
140
160
Day 1 Day 3 Day 8
PlasmaFreeHemoglobin
(mg/dL)
Blood Age
Human Porcine
n=4
Blood Damage Effects:
Both the human and porcine blood hemolysis levels were
affected similarly by the rocker bead fragility test, shown by the
graph below. The initial hemolysis level (t = 0) was always higher
for the porcine blood than it was for human blood. The RBC count
decreased in porcine blood with damage, but stayed constant in
human blood.
0
50
100
150
0 30
PlasmaFree
Hemoglobin(mg/dL)
Time (minutes)
Human n=2 Porcine n=4
Conclusions
RBC Count
(*1012
/L)
MCV (fL)
Platelet
Count
(*109
/L)
Plasma Free
Hb (mg/dL)
Human
Healthy 3.64 92.2 164 2.1
Damaged 3.68 92.2 167 112.7
Porcine Healthy 6.56 57.7 227 29.2
Damaged 5.86 57.9 270 137.3
• Human and porcine blood are affected similarly by mechanical
damage.
• Human blood with sodium citrate resulted in more hemolysis
due to aging than ACDA porcine blood.
• ACDA blood is more viable than sodium citrate blood over time,
as seen from the plasma free hemoglobin levels, glucose
concentration, and platelet count.
• P O2 increases in human blood as blood age increases.
Objectives and Significance
n=3
citrate, whereas the porcine blood contained ACDA. Thus, the
anticoagulant also likely plays a role in how the blood is damaged
over time.
Anticoagulant Effects:
ACDA resulted in much higher glucose levels compared to
sodium citrate. The blood gas levels were higher, and the pH was
lower, when using ACDA as opposed to sodium citrate.

More Related Content

What's hot

Current concept of fluid resuscitation 2013
Current concept of fluid resuscitation 2013Current concept of fluid resuscitation 2013
Current concept of fluid resuscitation 2013志道 周
 
Massive transfusion
Massive transfusionMassive transfusion
Massive transfusionRafiq Ahmad
 
Lab investigation
Lab investigationLab investigation
Lab investigation30122009
 
transfusion medicine
transfusion medicinetransfusion medicine
transfusion medicineMmedsc Hahm
 
Module 1 Critical Bleeding Massive Transfusion
Module 1 Critical Bleeding Massive TransfusionModule 1 Critical Bleeding Massive Transfusion
Module 1 Critical Bleeding Massive TransfusionKrstik
 
Hema practical 02 hematology
Hema practical 02 hematologyHema practical 02 hematology
Hema practical 02 hematologyMBBS IMS MSU
 
Blood and blood products in icu
Blood and blood products in icuBlood and blood products in icu
Blood and blood products in icuYasser Alwabli
 
Massive Transfusion In Trauma
Massive Transfusion In TraumaMassive Transfusion In Trauma
Massive Transfusion In Traumasromi
 
Haemoglobin Genotype
Haemoglobin GenotypeHaemoglobin Genotype
Haemoglobin GenotypeAgatsa David
 
Management of massive blood loss
Management of massive blood lossManagement of massive blood loss
Management of massive blood losssripalidassa
 
Blood & fluid administration copy
Blood & fluid administration   copyBlood & fluid administration   copy
Blood & fluid administration copyKIMS
 
Perioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and HaemostasisPerioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and HaemostasisAndrew Ferguson
 
Blood Volume Measurement
Blood Volume Measurement Blood Volume Measurement
Blood Volume Measurement drucsamal
 
2014 siset milano - pavesi - role of fresh frozen plasma, fibrinogen and pro...
2014 siset milano -  pavesi - role of fresh frozen plasma, fibrinogen and pro...2014 siset milano -  pavesi - role of fresh frozen plasma, fibrinogen and pro...
2014 siset milano - pavesi - role of fresh frozen plasma, fibrinogen and pro...anemo_site
 
Hydroxyethyl starch or saline for
Hydroxyethyl starch or saline forHydroxyethyl starch or saline for
Hydroxyethyl starch or saline forVishal Ramteke
 
Blood Transfusion: Rethinking who, what and when
Blood Transfusion: Rethinking who, what and whenBlood Transfusion: Rethinking who, what and when
Blood Transfusion: Rethinking who, what and whenSCGH ED CME
 
Fluid balance and therapy in critically ill
Fluid balance and therapy in critically illFluid balance and therapy in critically ill
Fluid balance and therapy in critically illAnand Tiwari
 
Anemo 2015-02-Hoffman- Considerazioni economiche nella PBM
Anemo 2015-02-Hoffman- Considerazioni economiche nella PBMAnemo 2015-02-Hoffman- Considerazioni economiche nella PBM
Anemo 2015-02-Hoffman- Considerazioni economiche nella PBManemo_site
 

What's hot (20)

Current concept of fluid resuscitation 2013
Current concept of fluid resuscitation 2013Current concept of fluid resuscitation 2013
Current concept of fluid resuscitation 2013
 
Massive transfusion
Massive transfusionMassive transfusion
Massive transfusion
 
Lab investigation
Lab investigationLab investigation
Lab investigation
 
transfusion medicine
transfusion medicinetransfusion medicine
transfusion medicine
 
Module 1 Critical Bleeding Massive Transfusion
Module 1 Critical Bleeding Massive TransfusionModule 1 Critical Bleeding Massive Transfusion
Module 1 Critical Bleeding Massive Transfusion
 
Hema practical 02 hematology
Hema practical 02 hematologyHema practical 02 hematology
Hema practical 02 hematology
 
Laboratory hematology
Laboratory hematologyLaboratory hematology
Laboratory hematology
 
Blood and blood products in icu
Blood and blood products in icuBlood and blood products in icu
Blood and blood products in icu
 
Massive Transfusion In Trauma
Massive Transfusion In TraumaMassive Transfusion In Trauma
Massive Transfusion In Trauma
 
Haemoglobin Genotype
Haemoglobin GenotypeHaemoglobin Genotype
Haemoglobin Genotype
 
Management of massive blood loss
Management of massive blood lossManagement of massive blood loss
Management of massive blood loss
 
Blood & fluid administration copy
Blood & fluid administration   copyBlood & fluid administration   copy
Blood & fluid administration copy
 
Perioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and HaemostasisPerioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and Haemostasis
 
Blood Volume Measurement
Blood Volume Measurement Blood Volume Measurement
Blood Volume Measurement
 
Examining Drug Candidates for Pulmonary Arterial Hypertension: Ups and Downs ...
Examining Drug Candidates for Pulmonary Arterial Hypertension: Ups and Downs ...Examining Drug Candidates for Pulmonary Arterial Hypertension: Ups and Downs ...
Examining Drug Candidates for Pulmonary Arterial Hypertension: Ups and Downs ...
 
2014 siset milano - pavesi - role of fresh frozen plasma, fibrinogen and pro...
2014 siset milano -  pavesi - role of fresh frozen plasma, fibrinogen and pro...2014 siset milano -  pavesi - role of fresh frozen plasma, fibrinogen and pro...
2014 siset milano - pavesi - role of fresh frozen plasma, fibrinogen and pro...
 
Hydroxyethyl starch or saline for
Hydroxyethyl starch or saline forHydroxyethyl starch or saline for
Hydroxyethyl starch or saline for
 
Blood Transfusion: Rethinking who, what and when
Blood Transfusion: Rethinking who, what and whenBlood Transfusion: Rethinking who, what and when
Blood Transfusion: Rethinking who, what and when
 
Fluid balance and therapy in critically ill
Fluid balance and therapy in critically illFluid balance and therapy in critically ill
Fluid balance and therapy in critically ill
 
Anemo 2015-02-Hoffman- Considerazioni economiche nella PBM
Anemo 2015-02-Hoffman- Considerazioni economiche nella PBMAnemo 2015-02-Hoffman- Considerazioni economiche nella PBM
Anemo 2015-02-Hoffman- Considerazioni economiche nella PBM
 

Similar to Naomi_Dereje_Poster (1)

03 laboratory tests part 1
03 laboratory tests part 103 laboratory tests part 1
03 laboratory tests part 1jhonee balmeo
 
complete blood count analysis and blood disease investigation
complete blood count analysis  and blood disease investigationcomplete blood count analysis  and blood disease investigation
complete blood count analysis and blood disease investigationMohamed Faramawy
 
Clinical Hematology Laboratory
Clinical Hematology LaboratoryClinical Hematology Laboratory
Clinical Hematology LaboratoryTapeshwar Yadav
 
CBC online and blood pictures PS 2.pptx
CBC online and blood pictures PS  2.pptxCBC online and blood pictures PS  2.pptx
CBC online and blood pictures PS 2.pptxKhetan4
 
interpretationofcbc-140424111626-phpapp02.pdf
interpretationofcbc-140424111626-phpapp02.pdfinterpretationofcbc-140424111626-phpapp02.pdf
interpretationofcbc-140424111626-phpapp02.pdfRathodBhavansinh
 
Interpretation of cbc
Interpretation of cbcInterpretation of cbc
Interpretation of cbcRakesh Verma
 
Wavelength selection in measuring red.pdf
Wavelength selection in measuring red.pdfWavelength selection in measuring red.pdf
Wavelength selection in measuring red.pdfbitconcepts
 
Lab investigations and interpretations in periodontics
Lab investigations and interpretations in periodonticsLab investigations and interpretations in periodontics
Lab investigations and interpretations in periodonticsAishwarya Hajare
 
Blood transfusion & its component therapy
Blood transfusion & its component therapyBlood transfusion & its component therapy
Blood transfusion & its component therapykitubhaimbbs
 
Automation in hematology
Automation in hematologyAutomation in hematology
Automation in hematologyDr Siddartha
 
Biomedical Instrumentation
Biomedical InstrumentationBiomedical Instrumentation
Biomedical Instrumentationlinsstalex
 
Data interpretation hematological
Data interpretation hematological Data interpretation hematological
Data interpretation hematological Ruhul Amin
 
9637a2ed-9b43-4645-aba0-950b8bc23296.pdf
9637a2ed-9b43-4645-aba0-950b8bc23296.pdf9637a2ed-9b43-4645-aba0-950b8bc23296.pdf
9637a2ed-9b43-4645-aba0-950b8bc23296.pdfkarenflores225
 
Kenyatta university, physiology pract 1
Kenyatta university, physiology pract 1Kenyatta university, physiology pract 1
Kenyatta university, physiology pract 1Lando Elvis
 

Similar to Naomi_Dereje_Poster (1) (20)

03 laboratory tests part 1
03 laboratory tests part 103 laboratory tests part 1
03 laboratory tests part 1
 
Blood test
Blood testBlood test
Blood test
 
complete blood count analysis and blood disease investigation
complete blood count analysis  and blood disease investigationcomplete blood count analysis  and blood disease investigation
complete blood count analysis and blood disease investigation
 
Clinical Hematology Laboratory
Clinical Hematology LaboratoryClinical Hematology Laboratory
Clinical Hematology Laboratory
 
CBC online and blood pictures PS 2.pptx
CBC online and blood pictures PS  2.pptxCBC online and blood pictures PS  2.pptx
CBC online and blood pictures PS 2.pptx
 
interpretationofcbc-140424111626-phpapp02.pdf
interpretationofcbc-140424111626-phpapp02.pdfinterpretationofcbc-140424111626-phpapp02.pdf
interpretationofcbc-140424111626-phpapp02.pdf
 
Interpretation of cbc
Interpretation of cbcInterpretation of cbc
Interpretation of cbc
 
Wavelength selection in measuring red.pdf
Wavelength selection in measuring red.pdfWavelength selection in measuring red.pdf
Wavelength selection in measuring red.pdf
 
Lab investigations and interpretations in periodontics
Lab investigations and interpretations in periodonticsLab investigations and interpretations in periodontics
Lab investigations and interpretations in periodontics
 
Hematology
HematologyHematology
Hematology
 
Heamatology test and techniques
Heamatology test and techniquesHeamatology test and techniques
Heamatology test and techniques
 
Heamatology test and techniques
Heamatology test and techniquesHeamatology test and techniques
Heamatology test and techniques
 
Blood transfusion & its component therapy
Blood transfusion & its component therapyBlood transfusion & its component therapy
Blood transfusion & its component therapy
 
Anemia - basic
Anemia - basicAnemia - basic
Anemia - basic
 
Automation in hematology
Automation in hematologyAutomation in hematology
Automation in hematology
 
Biomedical Instrumentation
Biomedical InstrumentationBiomedical Instrumentation
Biomedical Instrumentation
 
Blood
BloodBlood
Blood
 
Data interpretation hematological
Data interpretation hematological Data interpretation hematological
Data interpretation hematological
 
9637a2ed-9b43-4645-aba0-950b8bc23296.pdf
9637a2ed-9b43-4645-aba0-950b8bc23296.pdf9637a2ed-9b43-4645-aba0-950b8bc23296.pdf
9637a2ed-9b43-4645-aba0-950b8bc23296.pdf
 
Kenyatta university, physiology pract 1
Kenyatta university, physiology pract 1Kenyatta university, physiology pract 1
Kenyatta university, physiology pract 1
 

Naomi_Dereje_Poster (1)

  • 1. Background Materials and Methods In vitro blood testing is used in numerous settings including in laboratories and clinical offices. These diagnostic tests are used to detect a variety of medical complications. The reliability of such tools may be compromised by factors such as blood age, blood- device interactions, and the blood drawing procedure. Hemolysis, which refers to the rupture of red blood cells, releases hemoglobin into the plasma. Therefore, we have characterized healthy and damaged blood at different time points after it has been drawn to evaluate the viability of blood and to determine which blood parameters are likely to be affected. • To study and compare blood characteristics at different blood ages (time after blood draw) • To compare the blood characteristics and fragility parameters of different species (porcine, human). The results of this research are intended to improve in vitro blood testing methodologies. Blood Parameters: To study the change in blood characteristics due to blood aging, the blood was tested on different days. When not in use, the blood was kept refrigerated. The following conditions were used for testing: • Hematocrit was adjusted to 36% • Anticoagulation was achieved with either acid citrate dextrose solution A (ACDA) (for porcine and human blood) or 3.2% sodium citrate (for human blood only) • Blood Age: fresh blood (Day 1), Day 3 blood, and Day 8 blood • Blood Species: porcine and human Day 1 human Day 8 human plasma plasma Rocker Bead Fragility Test: Four tubes were rocked, with 15 stainless steel beads in each, in order to test blood fragility on Day 1. The following conditions were used for this test: • 3 mL of blood • 24º rocking angle • 30 minute run time • 30 cycles per minute Blood Characterization Tests: The density of each sample was found by weighing 1.000 ml of blood on a balance and making three measurements. A Complete Blood Count (CBC) System was used to determine the RBC count, WBC count, platelet count, and mean cell volume (MCV) of each blood sample. pH and partial pressure of oxygen (P O2) and carbon dioxide (P CO2) were measured using a blood gas analyzer. Plasma protein concentration was measured optically using a total solids refractometer. Blood and plasma viscosity and elasticity were measured by loading 0.5 ml of blood into an oscillatory rheometer, which uses a piston to generate oscillatory blood flow through a small diameter tube at known shear stresses. Viscosity was measured over a shear rate range of 5 to 1000 1/s. The Impact of Blood Age and Mechanical Damage on Measured Physical Parameters of Red Blood Cells Naomi Dereje, Luke Herbertson, Richard Malinauskas OSEL/Division of Applied Mechanics Results Blood Age Viscosity (cP) @ 1000 1/s Plasma Protein (g/dL) Glucose (mg/dL) P O2 (mmHg) P CO2 (mmHg) pH RBC Count (*1012 /L) MCV (fL) Platelet Count (*109 /L) Plasma Free Hb (mg/dL) Day 1 2.52±0.21 5.7±0.7 89±29 34±6 38±1 7.4±0 3.94±0.62 90.3±10.4 165±30 1.9±0.8 Human 3.2% Na Cit Day 3 2.88±0.61 6.3±0.7 60±13 50 42 7.3 4.08±0.12 84.4±2.1 114±57 28.2±8.6 Day 8 2.64±0.45 6.1±0.3 23±15 176 18 7.4 4.08±0.28 83.3±5.2 134±26 136.8±45.0 Day 1 2.47±0.04 6.1±0.6 418±40 71±6 67±15 6.8±0.1 6.78±0.81 55.1±2.7 247±80 14.0±5.7 Porcine ACDA Day 3 2.68±0.22 6.5±0.9 411±45 72±9 46±17 6.9±0.1 6.09±0.19 54.1±1.9 260±77 31.1±9.9 Day 8 2.64±0.18 6.6±0.6 411±34 82±7 36±3 6.9±0 6.03±0.28 55.0±2.6 278±78 53.7±10.3 The following table displays the different characteristics of each blood pool. For sodium citrate human blood we observed most of the parameters measured were not affected by blood age, however platelet count and P CO2 decreased while P O2 increased. For ACDA porcine blood, the difference is seen in the platelet count, which increased instead. Other trends are similar, but the anticoagulant appears to improve the long term viability of the blood. Blood Age Effects: The figure to the right compares the plasma free hemoglobin levels of human blood and porcine blood on each test day, showing the damage effects of blood aging. It should be noted that the human blood was anticoagulated with sodium 0 20 40 60 80 100 120 140 160 Day 1 Day 3 Day 8 PlasmaFreeHemoglobin (mg/dL) Blood Age Human Porcine n=4 Blood Damage Effects: Both the human and porcine blood hemolysis levels were affected similarly by the rocker bead fragility test, shown by the graph below. The initial hemolysis level (t = 0) was always higher for the porcine blood than it was for human blood. The RBC count decreased in porcine blood with damage, but stayed constant in human blood. 0 50 100 150 0 30 PlasmaFree Hemoglobin(mg/dL) Time (minutes) Human n=2 Porcine n=4 Conclusions RBC Count (*1012 /L) MCV (fL) Platelet Count (*109 /L) Plasma Free Hb (mg/dL) Human Healthy 3.64 92.2 164 2.1 Damaged 3.68 92.2 167 112.7 Porcine Healthy 6.56 57.7 227 29.2 Damaged 5.86 57.9 270 137.3 • Human and porcine blood are affected similarly by mechanical damage. • Human blood with sodium citrate resulted in more hemolysis due to aging than ACDA porcine blood. • ACDA blood is more viable than sodium citrate blood over time, as seen from the plasma free hemoglobin levels, glucose concentration, and platelet count. • P O2 increases in human blood as blood age increases. Objectives and Significance n=3 citrate, whereas the porcine blood contained ACDA. Thus, the anticoagulant also likely plays a role in how the blood is damaged over time. Anticoagulant Effects: ACDA resulted in much higher glucose levels compared to sodium citrate. The blood gas levels were higher, and the pH was lower, when using ACDA as opposed to sodium citrate.